Characteristics of and treatment outcomes in rifampicin-intolerant patients

BACKGROUND Rifampicin (RIF) is considered the backbone of TB treatment, but adverse effects often limit its use. METHODS This retrospective cohort study examined patients treated for TB disease at our institution, and compared those who received RIF to those who were intolerant to RIF. RESULTS A tot...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	IJTLD open 2024-04, Vol.1 (4), p.160-165
Hauptverfasser:	Mangat, R., Brode, S.K., Mah, H.K., Brar, M.S., Sabur, N.F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse Effects Original RIF rifabutin Treatment Intolerance Tuberculosis Treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!